http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2532436-R2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate | 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf51be6339d1441fc7d473681b04add8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a016e04ae59b05b7860510d7b61c025b |
publicationDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2532436-R2 |
titleOfInvention | USE OF AN INDOLIC COMPOUND WITH NUCLEOPHYLL SUBSTITUTES IN C3 AND ITS DIMERIC VARIANTS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF LYMPHOID NEOPLASIAS B. |
abstract | Use of an indole compound with nucleophilic substituents in C3 and their dimeric variants in the preparation of a pharmaceutical composition useful for the treatment of lymphoid B neoplasms. # The present invention relates to the use of an indole compound with nucleophilic substituents in C3 and its dimeric variants, which have activity against B lymphoid neoplasms selected from among chronic lymphatic leukemia / small B cell lymphoma, and B and Hodgkin lymphomas dependent on infection by Epstein-Barr herpesvirus and which are used in the preparation of a composition pharmaceutical, which has utility for the treatment of these pathologies. |
priorityDate | 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027 |
Total number of triples: 18.